RNU6-197P

Across TCGA pan-cancer cohorts, RNU6-197P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-197P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-197P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-197P expression acts as an unfavorable survival marker, although some lineages such as UCEC and LAML show a favorable association.

LUAD, THCA, and READ are the cancer types where RNU6-197P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.109	0.750	<.001	72	view →
THCA	DFS	Tertile	II,III,IV	0.144	0.878	<.001	60	view →
READ	DFS	Tertile	III,IV	0.400	0.775	.001	54	view →
BLCA	OS	Tertile	IV	0.063	0.576	<.001	48	view →
CHOL	OS	Tertile	All	0.024	0.675	<.001	36	view →
COAD	OS	Tertile	IV	0.082	0.659	<.001	36	view →
UCEC	DFS	Tertile	IV	1.000	0.370	.025	36	view →
KIRC	DFS	Tertile	IV	0.086	0.651	<.001	30	view →
PCPG	OS	Tertile	All	0.505	0.945	.004	27	view →
UCS	DFS	Tertile	All	0.128	0.449	.032	18	view →
LIHC	DFS	Tertile	All	0.158	0.555	.028	18	view →
LAML	DFS	Quartile	All	0.438	0.224	.010	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-197P–LUAD (OS)

Open the LUAD breakdown →